Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Gross Margin

Gilead Sciences Inc Gross Margin Chart (GILD)

Gilead Sciences Inc annual/quarterly Gross Margin from 2010 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Gilead Sciences Inc Gross Margin for the quarter ending September 09, 2020 was $83m a 13.65% increase of 11m year over year
  • Gilead Sciences Inc Gross Margin for the last 12 months ending September 09, 2020 was $79m a -0.20% decrease of 0m year over year
  • Gilead Sciences Inc Annual Gross Margin for 2019 was $79m a 1.40% increase of 1m from 2018
  • Gilead Sciences Inc Annual Gross Margin for 2018 was $78m a -6.65% decrease of -5m from 2017
  • Gilead Sciences Inc Annual Gross Margin for 2017 was $83m a -3.27% decrease of -3m from 2016
Other Margins & Efficiency Metrics:
  • Gilead Sciences Inc EBITDA Margin for the quarter ending December 12, 2018 was $26m a -90.33% decrease of -23m year over year
  • Gilead Sciences Inc Return on Capital % for the quarter ending December 12, 2018 was 5.53 a -87.56% decrease of -4.84 year over year
  • Gilead Sciences Inc Return on Equity % for the quarter ending December 12, 2018 was 0.05 a -55,717.16% decrease of -29.86 year over year
View Chart On Koyfin

Quarterly GILD Gross Margin Data

09/2020$83m
06/2020$79m
03/2020$83m
12/2019$71m
09/2019$82m
06/2019$82m
03/2019$82m
12/2018$73m
09/2018$81m
06/2018$79m

Annual GILD Gross Margin Data

2019$79m
2018$78m
2017$83m
2016$86m
2015$88m
2014$85m
2013$74m
2012$75m
2011$75m
2010$76m